683 Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History

683 Capital Management, LLC

$1.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.77 - $9.93 $60,694 - $104,453	-10,519 Reduced 35.63%	19,000 $188,000
Q4 2022 Feb 14, 2023	SELL	$5.08 - $7.09 $3.41 Million - $4.75 Million	-670,481 Reduced 95.78%	29,519 $205,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $7.74 $1.14 Million - $2.32 Million	-300,000 Reduced 30.0%	700,000 $3.74 Million
Q2 2022 Aug 15, 2022	BUY	$2.43 - $4.85 $1.22 Million - $2.43 Million	500,000 Added 100.0%	1,000,000 $3.99 Million
Q1 2022 May 16, 2022	BUY	$3.25 - $5.17 $1.63 Million - $2.59 Million	500,000 New	500,000 $2.22 Million
Q1 2021 May 17, 2021	SELL	$6.53 - $14.42 $1.42 Million - $3.13 Million	-216,818 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.31 - $8.13 $326,971 - $421,280	51,818 Added 31.4%	216,818 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$1.97 - $5.05 $1.5 Million - $3.84 Million	-760,000 Reduced 82.16%	165,000 $688,000
Q1 2020 May 15, 2020	SELL	$1.62 - $6.4 $1.3 Million - $5.14 Million	-802,700 Reduced 46.46%	925,000 $2.28 Million
Q4 2019 Feb 14, 2020	SELL	$4.73 - $7.98 $2.94 Million - $4.97 Million	-622,300 Reduced 26.48%	1,727,700 $10 Million
Q3 2019 Nov 14, 2019	BUY	$4.41 - $6.12 $988,805 - $1.37 Million	224,219 Added 10.55%	2,350,000 $12.4 Million
Q2 2019 Aug 14, 2019	BUY	$6.0 - $9.0 $1.95 Million - $2.93 Million	325,781 Added 18.1%	2,125,781 $12.8 Million
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $2.9 Million - $4 Million	406,300 Added 29.15%	1,800,000 $16.3 Million
Q4 2018 Feb 14, 2019	BUY	$7.26 - $13.29 $317,262 - $580,773	43,700 Added 3.24%	1,393,700 $11.6 Million
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $2.38 Million - $5.02 Million	350,000 Added 35.0%	1,350,000 $18.6 Million
Q1 2018 May 15, 2018	BUY	$6.55 - $8.9 $556,750 - $756,500	85,000 Added 9.29%	1,000,000 $7.5 Million
Q4 2017 Feb 15, 2018	SELL	$5.7 - $7.75 $1.14 Million - $1.55 Million	-200,000 Reduced 17.94%	915,000 $6.22 Million
Q4 2017 Feb 14, 2018	BUY	$5.7 - $7.75 $1.59 Million - $2.17 Million	279,486 Added 33.45%	1,115,000 $31.6 Million
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $3.26 Million - $9.02 Million	835,514	835,514 $6.02 Million

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$44.5 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$26.3 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$17.4 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.03 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account